Use of eiF-5A1 siRNA and antisense to treat sepsis or haemorrhagic shock

Details for Australian Patent Application No. 2007226875 (hide)

International Classifications

Event Publications

21 August 2008 PCT application entered the National Phase

PCT publication WO2007/109674 Priority application(s): WO2007/109674

11 September 2008 Amendment Made

The nature of the amendment is: Amend the invention title to read Use of eIF-5A1 siRNA and antisense to treat sepsis or haemorrhagic shock

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.